X
we'll ensure you
always get best
results.
contact usGO

Hebei Weimiao Import and Export Trade Co., Ltd. specializes in R&D, marketing, pharma API manufacturing, and pharmaceutical intermediates, we have two affiliated bulk drug manufacturers. More than 70 percent of API pharma products are exported to Europe, America, Japan, and Southeast Asia.

Our factory is located in Hebei, a beautiful coastal city in the east region of China.

.

know more about company
Hebei Weimiao Biology Co., LTD
explore our main services

Hebei Weimiao Import and Export Trade Co., Ltd. is a specialized and dynamic company dedicated to the research and development, manufacturing, and marketing of APIs (Active Pharmaceutical Ingredients) and pharmaceutical intermediates. With a commitment to excellence, we strive to deliver high-quality bulk pharmaceutical products that meet stringent industry standards. Our expertise lies in the production of essential components for the pharmaceutical sector, contributing to the advancement of healthcare solutions. Trust in Hebei Weimiao for reliable and innovative solutions in the field of API and pharmaceutical intermediate manufacturing.

we advice to choose
a right decision
  • our products
service_img
we'll ensure you always get
best results.
latest case studies

Hebei Weimiao Import and Export Trade Co., Ltd. showcases its strengths in precision manufacturing, customization, and global regulatory compliance, positioning itself as a reliable api pharmaceutical company and pharmaceutical intermediates manufacturer.

Inquiry for pricelist

Since its establishment, our factory has been developing first world class products with adhering the principle of quality first. Our products have gained excellent reputation in the industry and valuabletrusty among new and old customers..

submit now
latest news & blogs
view more
  • Active Pharmaceutical Ingredients (API)

    Active Pharmaceutical Ingredients (API)

    API enter surface waters from the discharges of sewage treatment plants or through their use in livestock production. Therefore the German federal states and the Federal Institute of Hydrology have been measuring select active pharmaceutical ingredients in surface waters for a number of years.Currently no environmental quality standards have been determined for API either at European or national level. However, monitoring programmes have been initiated at both levels which include measurements of API. A summary of all results 2016 - 2018 in Germany can be found at the end of this article.
    details
  • Niche Active Pharmaceutical Ingredients and How to Source Them

    Niche Active Pharmaceutical Ingredients and How to Source Them

    It’s the rise of niche APIs. They currently account for at least 25% of the market, and that percentage is expected to increase greatly in the near future.Global demand for active pharmaceutical ingredients (APIs) is growing fast. According to a report published earlier this year, market revenue is expected to grow from $185.23 billion in 2020 to $331.37 billion by the end of 2030 — an increase of nearly 79%.
    details
  • Sourcing of active pharmaceutical ingredients

    Sourcing of active pharmaceutical ingredients

    Considerations when sourcing active pharmaceutical ingredients (APIs) can often be condensed to ones of economy and purity. Here, Dave Elder highlights the importance of defining those attributes that impact final product quality to ensure pharma companies find the best ingredient suppliers.
    details

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


en_USEnglish